Company Profile
Nantong Chem-land Co., Ltd. is a reputable chemical company based in Nantong, Jiangsu, China. With a specialization in the production and distribution of various chemical products, the company has established itself as a leading provider in the region. Nantong Chem-land is well-known for its commitment to delivering high-quality products and exceptional customer service.
Since its establishment in 2009, Nantong Chem-land has experienced significant growth and has become a major player in the chemical industry. The company places a strong emphasis on research and development, enabling them to innovate and enhance their product offerings. By leveraging state-of-the-art manufacturing facilities and robust quality control systems, Nantong Chem-land ensures that all its products meet stringent standards of quality and safety.
In addition to chemical production, Nantong Chem-land offers a range of value-added services, including product formulation, packaging, and transportation. The company is dedicated to providing customized solutions that meet the specific needs and requirements of its customers, demonstrating its commitment to delivering outstanding service.
Nantong Chem-land's products find wide applications across various industries, such as agriculture, construction, and transportation. The company's expertise in chemical production, coupled with its customer-centric approach, has fostered trust and strong partnerships with businesses throughout the region.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate |
Carbonic acid,4-nitrophenyl 5-thiazolylmethyl ester;4-Nitrophenyl 5-thiazolylmethyl carbonate;(4-Nitrophenyl) thiazol-5-ylmethyl carbonate |
144163-97-3 | Pharma Grade / 98.5% | Inquiry |
(+/-)-Clopidogrel bisulfate |
Thieno[3,2-c]pyridine-5(4H)-acetic acid,α-(2-chlorophenyl)-6,7-dihydro-,methyl ester,sulfate (1:1);(±)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate hydrogen sulfate salt (1:1);(±)-Clopidogrel bisulfate;Methyl 2-(2-Chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate hydrogen sulfate;(RS)-Clopidogrel bisulfate;(RS)-Clopidogrel bisulfate;140623-71-8 |
135046-48-9 | Pharma Grade / 99.0% | Inquiry |
(2,2-Dichlorocyclopropyl)benzene |
Benzene,(2,2-dichlorocyclopropyl)-;(2,2-Dichlorocyclopropyl)benzene;1,1-Dichloro-2-phenylcyclopropane;2,2-Dichloro-1-phenylcyclopropane;2-Phenyl-1,1-dichlorocyclopropane;(±)-(2,2-Dichlorocyclopropyl)benzene;NSC 3003;144900-30-1 |
2415-80-7 | Pharma Grade / 99.0% | Inquiry |
(2,4-Dimethoxyphenyl)acetone |
1-(2,4-dimethoxyphenyl)propan-2-one;(2,4-Dimethoxyphenyl)acetone;2,4-Dimethoxyphenylacetone;1-(2,4-Dimethoxyphenyl)acetone;SCHEMBL267732;CTK8B6810;DTXSID10343758;ZINC2557007;1-(2,4-Dimethoxyphenyl)acetone #;ANW-54449 |
831-29-8 | Inquiry | |
(2S,3S,5S)-5-tert-Butyloxycarbonylamino-2-amino-3-hydroxy-1,6-diphenylhexane succinate |
Butanedioic acid,compd. with 1,1-dimethylethyl N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamate (1:2);Butanedioic acid,compd. with [1S-(1R*,3R*,4R*)]-1,1-dimethylethyl [4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamate (1:2);Butanedioic acid,compd. with 1,1-dimethylethyl [(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamate (1:2);Carbamic acid,[4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-,1,1-dimethylethyl ester,[1S-(1R*,3R*,4R*)]-,butanedioate (2:1) (salt);Carbamic acid,[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-,1,1-dimethylethyl ester,butanedioate (2:1) (salt);1,1-Dimethylethyl N-[(1S,3S,4S)-4-amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamate butanedioate (2:1) |
183388-64-9 | Inquiry | |
(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine |
3-Piperidinemethanol,4-(4-fluorophenyl)-1-methyl-,(3S,4R)-;3-Piperidinemethanol,4-(4-fluorophenyl)-1-methyl-,(3S-trans)-;(3S,4R)-4-(4-Fluorophenyl)-1-methyl-3-piperidinemethanol;(-)-trans-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine;Paroxol;(3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine;(-)-trans-4-(4′-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine;[(3S,4R)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl]methanol;trans-(4R,3S)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine;(-)-Paroxol;trans-Paroxol;((3S,4R)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl)methanol |
105812-81-5 | Inquiry | |
(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate |
1,3-Dioxane-4-acetic acid,6-(cyanomethyl)-2,2-dimethyl-,1,1-dimethylethyl ester,(4R,6R)-;1,3-Dioxane-4-acetic acid,6-(cyanomethyl)-2,2-dimethyl-,1,1-dimethylethyl ester,(4R-cis)-;1,1-Dimethylethyl (4R,6R)-6-(cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetate;(6R-Cyanomethyl-2,2-dimethyl-[1,3]dioxan-4R-yl)acetic acid tert-butyl ester;((4R,6R)-6-(Cyanomethyl)-2,2-dimethyl-[1,3]dioxan-4-yl)acetic acid tert-butyl ester |
125971-94-0 | Pharma Grade / 99% | Inquiry |
(4R-Cis)-6-Hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-acetic acid 1,1-dimethylethyl ester |
D-erythro-Hexonic acid,2,4-dideoxy-3,5-O-(1-methylethylidene)-,1,1-dimethylethyl ester;1,1-Dimethylethyl 2,4-dideoxy-3,5-O-(1-methylethylidene)-D-erythro-hexonate;2-[(4R,6S)-6-(Hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetic acid tert-butyl ester;(6S-Hydroxymethyl-2,2-dimethyl-[1,3]dioxan-4R-yl)acetic acid tert-butyl ester;((4R,6S)-6-Hydroxymethyl-2,2-dimethyl-[1,3]dioxan-4-yl)acetic acid tert-butyl ester;tert-Butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)acetate;tert-Butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl[1,3]dioxan-4-yl]acetate;tert-Butyl 2-[(4R,6S)-2,2-dimethyl-6-(hydroxymethyl)-1,3-dioxan-4-yl]acetate |
124655-09-0 | Pharma Grade / 98.0% | Inquiry |
(5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione |
(R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one;(5R)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-5-hydroxymethyl-2-oxazolidione;PNU-100440;UNII-V7V7QJB5QJ;V7V7QJB5QJ;(5R)-3-[3-FLUORO-4-(MORPHOLIN-4-YL)PHENYL]-5-(HYDROXYMETHYL)-1,3-OXAZOLIDIN-2-ONE;((r)-3-(3-fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methanol;(5R)-3-(3-Fluoro-4-morpholinophenyl)-5-(hydroxymethyl)oxazolidin-2-one;(5R)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-oxazolindinone;(5R)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-5-(hydroxymethyl)-2-Oxazolidinone |
168828-82-8 | Pharma Grade / 97.0% | Inquiry |
(6R,7R)-7-Amino-8-oxo-3-(1-propenyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-8-oxo-3-(1-propen-1-yl)-,(6R,7R)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-8-oxo-3-(1-propenyl)-,(6R-trans)-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-amino-8-oxo-3-(1-propenyl)-,(6R,7R)-;(6R,7R)-7-Amino-8-oxo-3-(1-propen-1-yl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;7 APCA |
120709-09-3 | Pharma Grade / 98% | Inquiry |
(E)-1,4-Dibromobut-2-ene |
2-Butene,1,4-dibromo-,(2E)-;2-Butene,1,4-dibromo-,(E)-;2-Butene,1,4-dibromo-,trans-;(2E)-1,4-Dibromo-2-butene;trans-1,4-Dibromo-2-butene;1,4-Dibromo-trans-2-butene;1,4-Dibromo-(E)-2-butene;(E)-1,4-Dibromo-2-butene;1,4-Dibromo-2-(E)-butene;(E)-1,4-Dibromo-2-butene;(2E)-1,4-Dibromobut-2-ene |
821-06-7 | Pharma Grade / 99% | Inquiry |
(R)-(+)-9-(2-Hydroxypropyl)adenine |
9H-Purine-9-ethanol,6-amino-α-methyl-,(αR)-;9H-Purine-9-ethanol,6-amino-α-methyl-,D-;9H-Purine-9-ethanol,6-amino-α-methyl-,(R)-;(αR)-6-Amino-α-methyl-9H-purine-9-ethanol;D-(-)-9-(2-Hydroxypropyl)adenine;9-[(2R)-2-Hydroxypropyl]adenine;(R)-9-(2-Hydroxypropyl)adenine;9-[2-(R)-(Hydroxy)propyl]adenine;(R)-(+)-9-(2-Hydroxypropyl)adenine;(2R)-1-(6-Aminopurin-9-yl)propan-2-ol;(R)-(+)-9-(2-Hydroxypropyl)adenine |
14047-28-0 | Pharma Grade / 97.0% | Inquiry |
(R)-(-)-3-Carbamoymethyl-5-methylhexanoic acid |
(r)-(-)-3-(2-amino-2-oxoethyl)-5-methylhexanoic acid;(r)-(-)-3-carbamoymethyl-5-methylhexanoic acid;INTERMEDIATE OF PREGABALIN;(3R)-3-(2-AMino-2-oxoethyl)-5-Methylhexanoic Acid;(R)-3-(2-AMINO-2-OXOETHYL)-5-METHYLHEXANOIC ACID:99+%;3-CarbaMoyl Mehyl-5-Methyl Hexanoic Acid;Pregabalin IMpurity III;Hexanoic acid,3-(2-aMino-2-oxoethyl)-5-Methyl-,(3R)- |
181289-33-8 | Inquiry | |
(R)-(-)-4-Phenyl-2-oxazolidinone |
2-Oxazolidinone,4-phenyl-,(4R)-;2-Oxazolidinone,4-phenyl-,(R)-;(4R)-4-Phenyl-2-oxazolidinone;(R)-4-Phenyl-2-oxazolidinone;(R)-(-)-4-Phenyl-2-oxazolidinone;4(R)-Phenyl-2-oxazolidinone;(-)-4-Phenyl-2-oxazolidinone;(R)-Phenyloxazolidinone;(R)-4-Phenyl-1,3-oxazolidin-2-one;(4R)-(-)-4-Phenyl-2-oxazolidinone;(4R)-4-Phenyl-1,3-oxazolidin-2-one;(4R)-4-Phenyl-1,3-oxazolidin-2-one;(4R)-4-Phenyloxazolidin-2-one;(R)-(-)-4-Phenyl-2-oxazolidinone |
90319-52-1 | Inquiry | |
(R)-4-Benzyl-2-oxazolidinone |
2-Oxazolidinone,4-(phenylmethyl)-,(4R)-;2-Oxazolidinone,4-(phenylmethyl)-,(R)-;(4R)-4-(Phenylmethyl)-2-oxazolidinone;(R)-4-(Phenylmethyl)-2-oxazolidinone;(R)-4-Benzyl-2-oxazolidinone;(R)-(+)-4-Benzyl-2-oxazolidinone;(4R)-4-Benzyl-2-oxazolidinone;(+)-4-Benzyl-2-oxazolidinone;(R)-4-Benzyl-1,3-oxazolidin-2-one;4(R)-Benzyloxazolidin-2-one;(R)-4-Benzyl-2-oxooxazolidine;(R)-(+)-4-Benzyl-2-oxazolidone;(4R)-4-Benzyl-1,3-oxazolidin-2-one;(R)-4-Benzyloxazolidin-2-one;(4R)-4-(Phenylmethyl)-1,3-oxazolidin-2-one;(R)-(+)-4-Benzyl-2-oxazolidinone;(R)-4-Benzyloxazolidin-2-one;(4R)-4-Benzyloxazolidin-2-one;167102-31-0 |
102029-44-7 | Pharma Grade / 99.5% | Inquiry |
(R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone |
2-Oxazolidinone,5-(azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-,(5R)-;2-Oxazolidinone,5-(azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-,(R)-;(5R)-5-(Azidomethyl)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxazolidinone;(R)-5-Azidomethyl-3-[3-fluoro-4-(morpholin-4-yl)phenyl]oxazolidin-2-one;(R)-[N-[3-Fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-5-oxazolidinyl]methyl azide;(R)-[3-(3-Fluoro-4-morpholin-4-ylphenyl)-2-oxo-5-oxazolidinyl]methyl azide;(5R)-5-(Azidomethyl)-3-(3-fluoro-4-morpholin-4-ylphenyl)-1,3-oxazolidin-2-one |
168828-84-0 | Pharma Grade / 97.5% | Inquiry |
(S)-(+)-2,2-Dimethylcyclopropanecarboxamide |
Cyclopropanecarboxamide,2,2-dimethyl-,(1S)-;Cyclopropanecarboxamide,2,2-dimethyl-,(S)-;(1S)-2,2-Dimethylcyclopropanecarboxamide;(+)-2,2-Dimethylcyclopropanecarboxamide;S-(+)-2,2-Dimethylcyclopropane-1-carboxamide;S-(+)-2,2-Dimethylcyclopropanecarboxamide;(S)-2,2-Dimethylcyclopropanecarboxamide;(1S)-2,2-Dimethylcyclopropane-1-carboxamide |
75885-58-4 | Pharma Grade / 99.0% | Inquiry |
(S)-(+)-4-Phenyl-2-oxazolidinone |
2-Oxazolidinone,4-phenyl-,(4S)-;2-Oxazolidinone,4-phenyl-,(S)-;(4S)-4-Phenyl-2-oxazolidinone;(S)-4-Phenyl-2-oxazolidinone;(S)-(+)-4-Phenyl-2-oxazolidinone;(+)-4-Phenyl-2-oxazolidinone;(S)-POZ;(S)-4-Phenyl-1,3-oxazolidin-2-one;(4S)-4-Phenyloxazolidin-2-one;(S)-POZ;(4S)-4-Phenyl-1,3-oxazolidin-2-one;175208-54-5 |
99395-88-7 | Pharma Grade / 99.0% | Inquiry |
(S)-(-)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)propanamine |
(S)-1-HYDROXY-1-(2-THIENYL)-3-DIMETHYLAMINOPROPANE;(S)-1-BETA-HYDROXY-1-(2-THIENYL)-3-DIMETHYLAMINOPROPANE;(S)-(-)-N-DIMETHYL-3-HYDROXY-3-(2-THIENYL)-PROPANAMINE;S-(-)-N,N-DIMETHYL-3-HYDROXY-3-(2-THIENYL)PROPANAMINE;(S)-N,N-dimethyl-3-hydroxy-3-(2-thienyl)-2-propanamine;Duloxetine intermediate AA;(S)-(-)-N,N-dimethyl-3-hydroxy-3-(2-thienyl)propylamine;(S)-N,N-Dimethyl-3-hydroxy-3-(2-thienyl)-1-propylamine |
132335-44-5 | Pharma Grade / 98.0% | Inquiry |
(S)-2-(3-((2-Isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic acid |
L-Valine,N-[[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]-;N-[[Methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl]-L-valine;(S)-2-(3-((2-Isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanoic acid |
154212-61-0 | Inquiry |
CONTACT INFORMATION
Sign In for Details